ArticleInternational journal of public health2026
Multiple cause of death during the COVID-19 pandemic: a population study In Colombia and Brazil.
Article in International journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To assess differences in age-standardized disease-specific mortality rates derived from the underlying cause of death (UCOD) versus multiple cause of death (MCOD) data in two Latin American countries during the COVID-19 pandemic. Methods: Using all death certificates for residents of Brazil (n = 6,207,785) and Colombia (n = 1,180,880) from 2019 through 2022, we extracted UCOD and all contributing causes, assigned weights (50% to UCOD, remainder equally among contributing causes), and calculated annual age- and sex-standardized mortality rates for neoplasms, circulatory diseases, diabetes mellitus (DM), and non-COVID communicable diseases. We then computed rate differences and rate ratios contrasting MCOD with UCOD estimates. Results: MCOD-DM mortality exceeded UCOD by up to 70%. In Colombia, MCOD-CVD surpassed UCOD during 2020-2021, corresponding to approximately 1,950 extra male and 1,560 extra female CVD deaths in 2021. Discrepancies for neoplasms and other communicable diseases were smaller and stable. Conclusion: These findings demonstrate that MCOD methods reveal substantial underestimation of diabetes- and cardiovascular-related mortality, underscoring the value of MCOD surveillance for public health planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.